Book a Meeting with a Pulmonary Specialist
Please fill out the form below to help us customize an experience tailored for your specific needs:
Recent Blogs
Dual Inhibition of ID1 and ID3 in Targeting Pulmonary Fibrosis
Idiopathic pulmonary fibrosis remains one of the most challenging respiratory diseases to treat, however new strategies that directly interrupt the cellular drivers of fibrosis are urgently needed.
Cardiopulmonary Impact of Wildfire Smoke
As global temperatures rise, wildfires are increasingly recognized as major public health crises. Exposure to wildfire smoke is known to worsen respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
Could a Novel BET Inhibitor Protect the Lungs from Secondhand Smoke?
Nearly half of the U.S. population remains at risk from the silent threat of secondhand smoke. Chronic exposure to triggers a cascade of inflammation and vascular damage that can lead to irreversible conditions like COPD and emphysema.
Integrating flexiVent and XV: Detecting Functional Impairment in Pre-Radiographic Lung Cancer
A recent pilot study by Smith et al (2025) has broken new ground by combining two
powerhouse technologies—the flexiVent and X-ray Velocimetry (XV)—to map the
functional decline of the lungs during tumor progression.